Drug Type Cell therapy |
Synonyms NXC 301, NXC-301, NXC301 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | US | 16 Mar 2023 | |
Large B-cell lymphoma | Preclinical | US | 16 Mar 2023 | |
Mantle-Cell Lymphoma | Preclinical | US | 16 Mar 2023 |